Fexofenadine 180 mg tablets recalled for failed impurity specifications
Sun Pharmaceutical Industries is recalling about 9,048 bottles of Fexofenadine Hydrochloride Tablets, USP 180 mg, distributed by Ohm Laboratories. The tablets failed impurities and degradation specifications. No injuries have been reported.
From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls
What to do
- Stop using the affected tablets and set the bottles aside.
- Check the lot number and expiration date on the bottle. The affected lots are DNG0283A (exp 03/31/2027), and DNF0922A and DNF0923B (exp 10/31/2026).
- Confirm the NDC on the label is 66336-561-30. This recall covers 150-tablet bottles.
- The notice doesn't say how to get a refund or replacement; ask Ohm Laboratories or where you bought it.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 9,048 bottles
- Illnesses reported
- None reported
- Manufactured in
- 2 Independence Way, N/A, Princeton, NJ, United States
- Classification
- Class III
- Recall number
- D-0654-2026
In the FDA's words
- Description
- Fexofenadine Hydrochloride Tablets, USP 180 mg, Antihistamine, 150 Tablets per bottle, Distributed by: Ohm Laboratories, Inc., New Brunswick, NJ 08901. NDC 66336-561-30 Failed Impurities/Degradation Specifications Lot, expiry: Lot DNG0283A, exp 03/31/2027; Lots DNF0922A and DNF0923B, exp 10/31/2026 Distribution: U.S. Nationwide Affected quantity: 9,048 bottles
- Hazard
- Failed Impurities/Degradation Specifications
More from Sun Pharmaceutical
See all- Sun Pharma sumatriptan-naproxen tablets recalled, failed dissolution
ModerateFDANov 18, 2026
- Sun Pharmaceutical lisdexamfetamine recalled for failed dissolution
ModerateFDANov 6, 2026
- Taro Tretinoin Cream 0.05% recalled for failed impurity specifications
ModerateFDAOct 14, 2026
- Sun nystatin cream recalled for failed stability specifications
ModerateFDASep 23, 2026
- Sun Pharmaceutical Carbamazepine 200mg tablets recalled for manufacturing defect
ModerateFDAAug 26, 2026